It can be reasonably postulated that the reason EGFR-TKI–resistant cells demonstrate significantly high expression of MMP-1 is that in EGFR-TKI–resistant lung adenocarcinoma cells, it is difficult to inhibit the increased EGFR pathway activity due to EGFR mutation. Here, EGFR is linked to lung adenocarcinoma.